Annexon appoints retinal expert to board
Annexon appointed Mark Blumenkranz to its board and bid farewell to long-time board member Muneer Satter, entering a growth phase with late-stage clinical programs.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day